News & Videos - Stocks - Page 8

Lam Research Corporation Reports Financial Results for the Quarter Ended March 31, 2024 PR Newswire FREMONT, Calif., April 24, 2024 FREMONT, Calif. , April 24, 2024 /PRNewswire/ -- Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended March 31, 2024 (the " March 2024 quarter"). Highlights for the March 2024 quarter were as follows: Revenue of $3.79 billion . U.S. GAAP gross margin of 47.5%, U.S. GAAP operating income as a...

BioMarin Reports Record Financial Results for the First Quarter 2024 PR Newswire SAN RAFAEL, Calif., April 24, 2024 First Quarter 2024 Total Revenues of $649 Million (+9% Y/Y and +13% at Constant Currency Y/Y); GAAP Diluted Earnings per Share (EPS) of $0.46 (+70% Y/Y) and Non-GAAP Diluted Earnings per Share of $0.71 (+18% Y/Y) VOXZOGO ® Net Product Revenues of $153 Million in Q1'24 (+74% Y/Y); Children Treated Increased Over 100% Y/Y For Full-year 2024 Guidance, Total Revenues Reaffirmed,...

Transaction provides company with an estimated approximately $128 million in cost savings, including approximately $67 million in clinical development and CMC costs over the next three years and an additional approximately $61 million in forecasted obligations through the patent life of rezafungin Cidara to further focus on advancing Cloudbreak development programs, including a planned IND filing for its lead oncology candidate, CBO421, as well as advancing other pipeline assets SAN DIEGO, April...

SEI Reports First-Quarter 2024 Financial Results PR Newswire OAKS, Pa., April 24, 2024 OAKS, Pa. , April 24, 2024 /PRNewswire/ -- SEI Investments Company (NASDAQ:SEIC) today announced financial results for the first-quarter 2024. Diluted earnings per share were $0.99 in first-quarter 2024 compared to $0.79 in first-quarter 2023. Consolidated Overview (In thousands, except earnings per share) For the Three Months Ended March 31, 2024 2023 % Revenues $511,579 $469,119 9 % Net income 131,400...

SAN MATEO, Calif. and CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced that it will present a study update of the oral CDK9 inhibitor KB-0742 in relapsed or refractory transcriptionally addicted advanced solid tumors from the ongoing Phase 1/2 trial, KB-0742-1001 ( NCT04718675 ), at the American Society of Clinical Oncology (ASCO) Annual Meeting, being held from May 31...

• Initial ACR-368 Phase 2b clinical data in patients with ovarian or endometrial cancers (n=26; 10 OncoSignature-positive and 16 OncoSignature-negative) are being presented • A 50% confirmed overall response rate observed with ACR-368 in OncoSignature-positive gynecological (ovarian and endometrial) cancers • Initial clinical validation of AP3 patient selection platform, demonstrated ability to prospectively predict ACR-368 RECIST responders ( p-value = 0.0038) • ACR-2316, a potential...

Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting PR Newswire NEWTON, Mass., April 24, 2024 Invited to Present Updated Endometrial Cancer Data During Special Session "ASCO Plenary Series: Rapid Abstract Updates" NEWTON, Mass. , April 24, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that several...

Cinco caballos del Ejército Británico se escaparon de una práctica y corrieron por las calles de la capital del Reino Unido ......

LOS ANGELES, April 24, 2024 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ: HNST), a personal care company dedicated to creating clean- and sustainably-designed products, today announced that it will report first quarter 2024 financial results after the market closes on Wednesday, May 8, 2024. The Company will host an investor conference call and webcast to review first quarter 2024 financial results at 1:30pm PT/4:30pm ET on the same day. The live webcast can be accessed at...

WALTHAM, Mass. and DUBLIN, Ireland, April 24, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announced an upcoming poster presentation at the American Society of Clinical Oncology (ASCO) annual meeting taking place May 31-June 4 in Chicago. The details are as follows: Recommended phase 2 dose...

Princeton Bancorp, Inc. Announces Declaration of a $0.30 Quarterly Cash Dividend PR Newswire PRINCETON, N.J., April 24, 2024 PRINCETON, N.J. , April 24, 2024 /PRNewswire/ -- Princeton Bancorp, Inc. (the "Company") (NASDAQ – BPRN), the bank holding company for The Bank of Princeton (the "Bank") announced that its Board of Directors, at a meeting held on April 24, 2024 , declared a cash dividend of $0.30 per share of the common stock of the Company. This dividend will be paid on May 31, 2024 to...

TGS Files 2023 Annual Report on Form 20-F PR Newswire BUENOS AIRES, Argentina, April 24, 2024 BUENOS AIRES, Argentina , April 24, 2024 /PRNewswire/ -- Transportadora de Gas del Sur S.A. ("tgs" or "the Company") (NYSE: TGS, MERVAL: TGSU2) announced that today it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 (the "2023 Annual Report") with the U.S. Securities and Exchange Commission (the "SEC"). The 2023 Annual Report can be accessed by visiting the Company's...

FORT LAUDERDALE, FL, April 24, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Splash Beverage Group, Inc. (NYSE American: SBEV) ("Splash" or the "Company"), a portfolio company of leading beverage brands, today announced the appointment of Julius Ivancsits as Chief Financial Officer effective April 24th, 2024. Julius is a growth strategist with proven success scaling Public & PE-backed companies in both CPG and B2B organizations. “In addition, his prior experience in full deal cycle (diligence...

Analog Devices, Inc. to Report Second Quarter Fiscal Year 2024 Financial Results on Wednesday, May 22, 2024 PR Newswire WILMINGTON, Mass., April 24, 2024 WILMINGTON, Mass. , April 24, 2024 /PRNewswire/ -- Analog Devices, Inc. (Nasdaq: ADI ) today announced it will release financial results for the second quarter fiscal year 2024 at 7:00 a.m. Eastern time on Wednesday, May 22, 2024. Following the press release, the Company will host a conference call at 10:00 a.m. Eastern time, the same day....

LOS ANGELES, April 24, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), the healthcare industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), celebrates the grand opening of its newest center in California. As part of this launch, InnovAge California PACE will host a lively celebration today, welcoming local officials, community organizations, care partners, and the...

Late-breaking oral presentation on results from Phase 1/2 study of FLT201 in Gaucher disease Poster presentation to highlight Freeline’s GBA1 Parkinson’s disease research program LONDON, April 24, 2024 (GLOBE NEWSWIRE) -- Freeline Therapeutics today announced the acceptance of multiple abstracts, including one for a late-breaking oral presentation on new clinical data from its Gaucher disease program, at the upcoming American Society of Gene and Cell Therapy (ASGCT) 27 th Annual Meeting...

Synopsys Accelerates Next-Level Chip Innovation on TSMC Advanced Processes PR Newswire SUNNYVALE, Calif., April 24, 2024 Collaboration on AI-Driven Design Flows for Optimization and Productivity, Advancements in Photonic IC Integration, Plus Broad IP Development on TSMC 2nm Technology Highlights: Production-ready digital and analog design flows, powered by Synopsys.ai™ EDA suite , on TSMC N3/N3P and N2 drive successful results and accelerate analog design migration Certified Synopsys physical...

Miami (EE.UU.), 24 abr (EFE/EPA).- La vida del astro del fútbol Lionel Messi y su rosario de triunfos han sido llevadas a una ......

Automation Anywhere nombra a Tim McDonough como director de marketing para impulsar la conciencia global y el crecimiento del líder en automatización impulsada por IA PR Newswire SAN JOSÉ, California, 24 de abril de 2024 SAN JOSÉ, California , 24 de abril de 2024 /PRNewswire/ -- Automation Anywhere, líder en soluciones de automatización impulsadas por IA, anunció que el líder de marketing de IA, Tim McDonough, se unió a la compañía como director de marketing (CMO). McDonough, que...

Roberto Salis, padre de Ilaria, habló en el Parlamento Europeo en Estrasburgo, donde explicó los motivos de la candidatura de ......